Sign in
Active, not recruitingPhase 1

NFL LONG Prospective Study

Key facts

Who runs it
University of North Carolina, Chapel Hill
Where
Chapel Hill, Milwaukee, and Waltham, United StatesSee the 3 sites
Trial code
Status
Active, not recruiting
Phase
Phase 1
People taking part
250 people, planned
Started
12 Mar 2020
Expected to end
Aug 2028
Type of study
Interventional, 10 groups
Treatments tested
  • [11C] PiB
  • [18F] PBR111
  • [18F] Flortaucipir
Record updated
22 April 2026

Who can take part

Age
50 years to 70 years
Sex
Men only
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • At least 1 year of participation in National Football League (NFL groups)
  • Retired from professional football
  • Ages between 50-70
  • No prior exposure to football, collision sports, or prior concussions
  • They will be matched to former NFL players by age and estimated premorbid intellectual functioning
  • Ages between 50-70

Who cannot take part

  • History of Moderate or Severe TBI
  • Current primary Axis I diagnosis of Psychotic Disorder
  • History or clinical suspicion of other conditions (e.g., epilepsy, stroke, dementia) known to cause cognitive dysfunction
  • Diagnosis /associated treatment that would preclude participation in full study protocol (e.g., terminal cancer)
  • Any contraindications to MRI, PET, or biological study procedures

Where in United States

  • University of North Carolina at Chapel HillChapel Hill, United States
  • Medical College of WisconsinMilwaukee, United States
  • Boston Children's HospitalWaltham, United States

About the trial

What the trial wants to find out

The purpose of this 5-year prospective research study is to characterize the association between concussions, sub-concussive exposure, and long-term neurologic health outcomes in former NFL players. To achieve the study aims, the investigators will conduct detailed research visits that include clinical outcome assessments, blood-based biomarkers, advanced magnetic resonance imaging (MRI), positron emission tomography (PET) using investigational tracers and genetic testing. Ultimately, the goal of this study is to translate the findings from this study into clinical, interventional studies for at risk former NFL players.

The 10 groups in the trial

  • Low Cognitive Functioning/Low Concussion HistoryOther group

    Former NFL players with low cognitive function and low concussion history will be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • High Cognitive Functioning/ High Concussion HistoryOther group

    Former NFL players with high cognitive function and high concussion history will be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • Low Cognitive Functioning/High Concussion HistoryOther group

    Former NFL players with low cognitive function and high concussion history will be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • High Cognitive Functioning/Low Concussion HistoryOther group

    Former NFL players with high cognitive function and low concussion history will be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • Healthy Male ControlsOther group

    Healthy male demographically matched controls will be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • Low Cognitive Functioning/Medium Concussion HistoryOther group

    Former NFL players with low cognitive function and medium concussion history will be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • Medium Cognitive Functioning/Low Concussion HistoryOther group

    Former NFL Players with medium cognitive functioning and low concussion history with be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • Medium Cognitive Functioning/Medium Concussion HistoryOther group

    Former NFL Players with medium cognitive functioning and medium concussion history with be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • Medium Cognitive Functioning/High Concussion HistoryOther group

    Former NFL Players with medium cognitive functioning and high concussion history with be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

  • High Cognitive Functioning/Medium Concussion HistoryOther group

    Former NFL Players with high cognitive functioning and high concussion history with be included in this group.

    Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Neurologic Function Across the Lifespan: A Prospective, LONGitudinal, and Translational Study for Former National Football League Players
Record updated
22 April 2026